REMEDI Co., Ltd.
PrivateLast Round
IPO
Jul 13, 2026
Est. Valuation
$105.27M
Total Funding Raised
$2.17M
Company Overview
REMEDI Co., Ltd. operates in Healthcare & Life Sciences and is based in Incheon. Its latest recorded funding round was a VC Round in April 2022.
REMEDI Co., Ltd. is a biotechnology company that develops peptide-based biomedical products for therapeutic and cosmetic applications using an AI-driven cell-penetrating peptide platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
REMEDI Co., Ltd. Comparables
Compare REMEDI Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeoRegen Biotech | 81% | |
| ProCell Therapeutics, Inc. | 76% | |
| Icure Pharmaceutical Inc. | 71% |
For institutional investors. Book with your work email.
REMEDI Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jul 13, 2026 | ||||
| VC Round | Apr 1, 2022 | ||||
| Strategic | Jun 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
REMEDI Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KB Securities | IPO |
| InterValue Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Monthly visitors increased 32% MoM.
- Jan 25, 2025
Monthly visitors grew 220% MoM.
For institutional investors. Book with your work email.
REMEDI Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about REMEDI Co., Ltd.'s valuation, stock price, and market status.
Is REMEDI Co., Ltd. a public or private company?
REMEDI Co., Ltd. is a private company.
What is the current stock price of REMEDI Co., Ltd.?
REMEDI Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks REMEDI Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is REMEDI Co., Ltd. worth (valuation)?
REMEDI Co., Ltd.'s valuation is estimated at $105.3M based on funding round data.
Can I buy REMEDI Co., Ltd. stock?
REMEDI Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was REMEDI Co., Ltd.'s last funding round?
REMEDI Co., Ltd.'s most recent funding round was IPO on July 13, 2026.
Who are the main investors in REMEDI Co., Ltd.?
Key investors in REMEDI Co., Ltd. include InterValue Partners.
Will REMEDI Co., Ltd. IPO soon?
No public IPO plans have been announced for REMEDI Co., Ltd..
How can I track REMEDI Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in REMEDI Co., Ltd.'s shares on secondary markets.